|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/015 | |
| C12N 15/864 | |||
| A61K 39/23 |
| (11) | Number of the document | 3356390 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16852471.8 |
| Date of filing the European patent application | 2016-09-28 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/054143 |
| Date | 2016-09-28 |
| (87) | Number | WO 2017/058892 |
| Date | 2017-04-06 |
| (30) | Number | Date | Country code |
| 201562234016 P | 2015-09-28 | US |
| (72) |
ASOKAN, Aravind, US
AGBANDJE-MCKENNA, Mavis, US
TSE, Long Ping Victor, US
GURDA, Brittney, US
|
| (73) |
University of Florida Research Foundation, Inc.,
223 Grinter Hall, Gainesville, FL 32611,
US
The University of North Carolina at Chapel Hill, 109 Church Street, Chapel Hill NC 27516, US |
| (54) | METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS |
| METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS |